Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial
Kappos, Ludwig, Arnold, Douglas L, Bar-Or, Amit, Camm, John, Derfuss, Tobias, Kieseier, Bernd C, Sprenger, Till, Greenough, Kristin, Ni, Pingping, Harada, TomohikoLanguage:
english
Journal:
The Lancet Neurology
DOI:
10.1016/S1474-4422(16)30192-2
Date:
August, 2016
File:
PDF, 295 KB
english, 2016